AVIA Vascular

AVIA Vascular is a private, commercial-stage medical device company developing needle-free vascular access solutions to mitigate venous depletion and improve the patient experience. Its lead product, The Ally, is a blood collection device intended to reduce the need for repeated venipuncture in hospitalized patients. The company, founded in 2019 and headquartered in San Jose, California, is a subsidiary of MedVenture Health, which provides strategic capital and expertise. AVIA Vascular aims to establish a new standard of care by preserving vasculature and reducing needle-stick risks for both patients and healthcare providers.

Needle-free or needle-reducing vascular access platform for blood collection and infusion therapy, focused on preserving vasculature and mitigating venous depletion.

AVIA Vascular competes in the vascular access device market against giants like Becton Dickinson, B. Braun, and ICU Medical, who offer integrated needle-free connectors and blood draw systems. Its differentiation lies in a focused mission on vessel preservation and a product specifically designed to eliminate separate venipuncture for inpatients with existing access.